STOCK TITAN

Solventum to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Solventum (NYSE: SOLV), a healthcare company, has announced its participation in two upcoming investor conferences. The first is the 2024 Wells Fargo Healthcare Conference in Everett, MA on September 4, 2024, at 11:00 a.m. ET. The second is the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on September 5, 2024, at 11:30 a.m. ET.

These conferences provide Solventum with opportunities to present to investors and analysts. The company will offer live and archived audio webcasts of their presentations on their investor relations website at investors.solventum.com, allowing wider access to their updates and strategies.

Solventum (NYSE: SOLV), un'azienda del settore sanitario, ha annunciato la sua partecipazione a due prossime conferenze per investitori. La prima è la Conferenza Sanitaria Wells Fargo 2024 a Everett, MA, il 4 settembre 2024, alle 11:00 ET. La seconda è la 22ª Conferenza Sanitaria Globale Annuale di Morgan Stanley a New York, NY, il 5 settembre 2024, alle 11:30 ET.

Queste conferenze offrono a Solventum l'opportunità di presentarsi a investitori e analisti. L'azienda offrirà webcast audio in diretta e registrati delle proprie presentazioni sul sito web delle relazioni con gli investitori all'indirizzo investors.solventum.com, consentendo un accesso più ampio ai loro aggiornamenti e strategie.

Solventum (NYSE: SOLV), una empresa de atención médica, ha anunciado su participación en dos próximas conferencias para inversores. La primera es la Conferencia de Atención Médica Wells Fargo 2024 en Everett, MA, el 4 de septiembre de 2024, a las 11:00 a.m. ET. La segunda es la 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley en Nueva York, NY, el 5 de septiembre de 2024, a las 11:30 a.m. ET.

Estas conferencias brindan a Solventum oportunidades para presentarse a inversores y analistas. La empresa ofrecerá webcasts de audio en vivo y grabados de sus presentaciones en su sitio web de relaciones con inversores en investors.solventum.com, lo que permite un acceso más amplio a sus actualizaciones y estrategias.

솔벤트럼(Solventum, NYSE: SOLV)은 의료 회사로서 두 개의 다가오는 투자자 컨퍼런스에 참가할 것이라고 발표했습니다. 첫 번째는 2024년 9월 4일 매사추세츠주 에버렛에서 열리는 2024 웰스파고 의료 컨퍼런스이며, 시간은 오전 11시(ET)입니다. 두 번째는 2024년 9월 5일 뉴욕에서 열리는 모건 스탠리 제22회 글로벌 의료 컨퍼런스이며, 시간은 오전 11시 30분(ET)입니다.

이 컨퍼런스는 솔벤트럼에게 투자자 및 분석가들에게 발표할 기회를 제공합니다. 이 회사는 투자자 관계 웹사이트인 investors.solventum.com에서 발표의 실시간 및 녹화된 오디오 웹캐스트를 제공하여 그들의 업데이트와 전략에 더 넓은 접근을 가능하게 할 것입니다.

Solventum (NYSE: SOLV), une entreprise de santé, a annoncé sa participation à deux conférences d'investisseurs à venir. La première est la Conférence sur la santé Wells Fargo 2024 à Everett, MA, le 4 septembre 2024, à 11 h 00 HAE. La seconde est la 22ème Conférence mondiale annuelle Morgan Stanley sur la santé à New York, NY, le 5 septembre 2024, à 11 h 30 HAE.

Ces conférences offrent à Solventum des opportunités de se présenter aux investisseurs et aux analystes. L'entreprise proposera des webcasts audio en direct et archivés de ses présentations sur son site web de relations avec les investisseurs à investors.solventum.com, permettant un accès plus large à ses mises à jour et stratégies.

Solventum (NYSE: SOLV), ein Gesundheitsunternehmen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Die erste ist die 2024 Wells Fargo Healthcare Conference in Everett, MA, am 4. September 2024 um 11:00 Uhr ET. Die zweite ist die 22. jährliche globale Gesundheitskonferenz von Morgan Stanley in New York, NY, am 5. September 2024 um 11:30 Uhr ET.

Diese Konferenzen bieten Solventum die Möglichkeit, sich Investoren und Analysten zu präsentieren. Das Unternehmen wird live und aufgezeichnete Audio-Webcasts seiner Präsentationen auf seiner Investor-Relations-Website unter investors.solventum.com anbieten, was einen breiteren Zugang zu seinen Updates und Strategien ermöglicht.

Positive
  • None.
Negative
  • None.

ST. PAUL, Minn., Aug. 28, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences:

  • 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m. ET.
  • Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Thursday, September 5, 2024 at 11:30 a.m. ET.

Live and archived audio webcasts will be available on the company's website at investors.solventum.com.   

About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-to-participate-in-upcoming-investor-conferences-302232297.html

SOURCE Solventum

FAQ

When and where is Solventum (SOLV) participating in the Wells Fargo Healthcare Conference?

Solventum (SOLV) is participating in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 11:00 a.m. ET in Everett, MA.

What is the date and location of Solventum's (SOLV) presentation at the Morgan Stanley Global Healthcare Conference?

Solventum (SOLV) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 11:30 a.m. ET in New York, NY.

How can investors access Solventum's (SOLV) presentations at the upcoming conferences?

Investors can access live and archived audio webcasts of Solventum's (SOLV) presentations at the upcoming conferences through the company's website at investors.solventum.com.

What is the stock symbol for Solventum?

The stock symbol for Solventum is SOLV, and it is listed on the New York Stock Exchange (NYSE).

Solventum Corporation

NYSE:SOLV

SOLV Rankings

SOLV Latest News

SOLV Stock Data

11.55B
138.28M
19.96%
62.86%
2.2%
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States of America
ST. PAUL